The hepatitis delta virus (HDV) is an RNA virus that depends on DNA-dependent RNA polymerase (RNAP) for its transcription and replication. While it is generally accepted that RNAP II is involved in HDV replication, its interaction with HDV RNA requires confirmation. A monoclonal antibody specific to the carboxy terminal domain of the largest subunit of RNAP II was used to establish the association of RNAP II with both polarities of HDV RNA in HeLa cells. Co-immunoprecipitations using HeLa nuclear extract revealed that RNAP II interacts with HDVderived RNAs at sites located within the terminal stem-loop domains of both polarities of HDV RNA. Analysis of these regions revealed a strong selection to maintain a rod-like conformation and demonstrated several conserved features. These results provide the first direct evidence of an association between human RNAP II and HDV RNA and suggest two transcription start sites on both polarities of HDV RNA.
Introduction
The hepatitis delta virus (HDV) is a subviral satellite virus of the hepatitis B virus (HBV) and is composed of a singlestranded, circular RNA molecule of approximately 1700 nucleotides (Chen et al., 1986) . Its genome forms an unbranched, rod-shaped structure with a high proportion of canonical base pairing, contains two complementary ribozyme motifs (i.e. delta ribozymes), and has a single open reading frame producing two viral proteins (HDAgs; Fig. 1 ; Taylor, 2006) . These two proteins are identical in sequence, except that the large HDAg (HDAg-L) contains 19 additional amino acids at its C-terminus resulting from RNA editing of the termination codon of the small HDAg (HDAg-S) gene (Casey et al., 1992; Wang et al., 1992; Weiner et al., 1988; Xia et al., 1990) . Each protein has a distinct function: HDAg-S (195 amino acids) is essential for HDV accumulation, while the HDAg-L (214 amino acids) is required for virion assembly and is reported to be a dominant negative inhibitor of replication (Chang et al., 1991; Kuo et al., 1989; Ryu et al., 1992) .
Although HDV requires HBV for encapsidation and transmission, it relies entirely on its host for replication. HDV replicates through a symmetrical rolling circle mechanism that involves only RNA intermediates (Chen et al., 1986; Kuo et al., 1988a,b; Lai, 2005; Taylor, 2006) . Replication of the genomic circular monomer produces linear, multimeric strands which are subsequently self-cleaved and ligated, resulting in antigenomic polarity circular monomers. This process is repeated to generate the genomic RNA, which is found at a greater intracellular abundance than the antigenomic species (Chen et al., 1986) . Because HDV does not encode its own replicase, host DNAdependent RNA polymerases (RNAPs) are considered to be involved in the replication and transcription of HDV RNA (Lai, 2005) .
Many studies using cultured cells and cell extracts have suggested that RNAP II might be responsible for HDV replication based on the sensitivity of the accumulation of HDV mRNA and processed unit-length genomic HDV RNAs to low levels of α-amanitin, a mycotoxin that inhibits DNAdependent RNA synthesis by RNAP II (de Mercoyrol et al., 1989; Filipovska and Konarska, 2000; Fu and Taylor, 1993; Macnaughton et al., 1991) . This hypothesis was substantiated by experiments using cells containing an α-amanitin-resistant allele of the largest subunit of RNAP II, which partially relieved transcription inhibition by α-aminitin (Modahl et al., 2000) . RNAP II is furthermore speculated to be involved in the transcription of the HDAg mRNA because, in vivo, this mRNA was shown to be post-transcriptionally processed with a 5′-cap and a 3′-poly(A) tail, which are typical features of transcripts generated by RNAP II (Gudima et al., 2000; Nie et al., 2004) . Additionally, in in vitro transcription assays using nuclear extract (NE) from HeLa cells and RNA derived from the left terminal stem-loop domain of HDV antigenomic RNA, synthesis of the complementary strand was possible (Filipovska and Konarska, 2000) . Accumulation of this RNA product was highly sensitive to α-amanitin. This sensitivity was partially abrogated in experiments conducted in NE from cells containing an α-amanitin-resistant allele of the largest subunit of RNAP II, suggesting the involvement of RNAP II in this reaction. Interestingly, the transcription did not proceed by de novo initiation, but rather by cleavage of the RNA template followed by extension of the new 3′-end, generating a chimeric template/transcript product.
Conversely, the accumulation of the antigenomic RNA species has been shown to be resistant to a higher dose of α-amanitin, suggesting the involvement of another yet unknown RNAP in the life cycle of HDV (Macnaughton et al., 2002; Modahl et al., 2000) . It has been hypothesized that RNAP I or an RNAP I-like polymerase might be involved in HDV replication because antigenomic HDV RNAwas shown to accumulate in the nucleolus and its synthesis is associated with the RNAP Ispecific transcription factor SL1 (Li et al., 2006) .
Because general host DNA-directed RNAP II transcription is inhibited at relatively low doses of α-amanitin (de Mercoyrol et al., 1989) , the observed inhibition of HDV RNA accumulation in the presence of this transcription inhibitor might be an indirect rather than a direct effect. It is difficult to differentiate between specific inhibition of HDV replication and non-specific toxic effects on host cells or the need for some additional host DNA-directed RNAP II transcripts. In addition, because the enzymes involved in HDV transcription/replication are host DNA-dependent RNAPs coerced to use an RNA template, sensitivity of RNAP II, or any other host RNAP(s), to α-amanitin might be affected by the nature of the template (i.e. RNA versus DNA). Such a phenomenon was reported for actinomycin D (Meienhofer and Atherton, 1973; Pelchat and Perreault, 2004) and was recently observed with tagetitoxin (Pelchat et al., 2001 ), a potent inhibitor of bacterial RNAP and nuclear DNA-dependent RNAP III (Mathews and Durbin, 1994) . Like α-amanitin, tagetitoxin is believed to inhibit the elongation phase of RNA synthesis by interacting with the ternary complex that contains the RNAP, the template, and the nascent RNA (Mathews and Durbin, 1994; Gong et al., 2004) . RNAP inhibitors must thus be used with caution when utilized as a means of identifying an RNAP involved in RNA-dependent transcription.
Although HDV replication has been shown to be sensitive to low concentrations of α-amanitin, suggesting RNAP II activity, no direct interaction between RNAP II and HDV RNA has been reported. The present study was undertaken (i) to confirm the association of RNAP II with HDV RNA, and (ii) to identify the regions on the HDV RNA genome responsible for this interaction. To this end, we took advantage of an antibody raised against the carboxy terminal domain (CTD) of RNAP II to clarify the interaction of RNAP II with HDV RNA by directly examining their association in vivo within HeLa cells. We identified the regions involved in this interaction by coimmunoprecipitating various HDV-derived RNAs with RNAP II using HeLa nuclear extract (NE) and the anti-RNAP II antibody. Then, we used covariation analysis on natural variants to analyze the conserved nucleotides and structural motifs of the interaction sites of RNAP II on HDV RNA. Our analyses support a role for the human RNAP II in the life cycle of HDV by demonstrating its association with HDV RNA in vivo and with the terminal stem-loop domains of both polarities of HDV RNA in vitro.
Results

RNAP II interacts with HDV RNA within HeLa cells
To establish the direct interaction between RNAP II and HDV RNA in vivo, we immunoprecipitated RNAP II from HeLa cells containing both polarities of HDV RNA and tested for the presence of viral RNA in the immunoprecipitated samples. To this end, we used the monoclonal antibody (mAb) 8WG16 which was raised against wheat germ RNAP II and found to recognize epitopes conserved among the CTDs of RNAP IIs derived from a variety of different eukaryotes (Thompson et al., 1989) . When this commonly used antibody is tested against HeLa NE proteins, only one band corresponding to the largest subunit of RNAP II is revealed by Western blot. To obtain cells harboring both polarities of HDV RNA, HeLa cells were transiently transfected with a dimeric HDV transcript of genomic polarity and a eukaryotic expression vector overexpressing HDAg-S, which has been found to be essential for HDV RNA accumulation (Kuo et al., 1989) . Four days post-transfection, the cells were harvested and the RNA-protein complexes cross-linked with formaldehyde in vivo using the ribonucleoprotein immunoprecipitation (RIP) assay developed by Niranjanakumari et al. (2002) . Following immunoprecipitation and high-stringency washes to ensure the specificity of the binding, the cross-links were reversed by heating the samples. Recovered nucleic acids were then extracted and subjected to RT-PCR. For this step, we used primers for a cDNA fragment corresponding to what we refer to as the right-terminal stem-loop domain of HDV (Fig. 1,  R199GFW and R199GREV ). In addition to the HDV sequence (nucleotides 1541 to 61), the 232 bp cDNA fragment generated after RT-PCR included a promoter for the T7 RNAP and recognition sites for restriction enzymes. When we used the 8WG16 mAb to immunoprecipitate the sample, cDNA fragments corresponding to both polarities of R199 were detected (Fig. 2, 8WG16 lanes). Cloning and subsequent sequence analysis confirmed the identity of the HDV-derived cDNA fragments. These cDNA fragments were detected neither in the control reactions lacking antibody nor in the goat anti-mouse IgG mAb control reactions (Fig. 2) , indicating that cDNAs obtained from this assay were specific to the samples immunoprecipitated with the 8WG16 mAb. Moreover, these fragments were also absent from samples that were not subjected to the cross-linking reaction prior to co-immunoprecipitation (Fig. 2 , No-XL 8WG16 lanes). To ascertain that the association with the RNAP II complex is specific for HDV RNA, RT-PCR was also performed on an abundant cellular RNA (β-actin mRNA). As shown in Fig. 2B , although the β-actin cDNA fragment was easily amplified from crude extract from HeLa cells, this fragment was not detected in the various immunoprecipitation reactions performed above. Overall, the presence of HDV RNA fragments in the cross-linked, immunoprecipitated samples provides evidence that formaldehyde covalently crosslinks the largest subunit of RNAP II or a complex containing RNAP II to HDV RNA in HeLa cells. To corroborate this finding, we used a pair of primers corresponding to the other terminal stem-loop region of the HDV RNA genome (i.e. L213, nucleotides 687 to 900); identical results were obtained (data not shown).
The primers used in the RT reactions were designed to differentiate between both polarities of HDV RNA. Specifically, primers corresponding to sequences of the genomic (i.e. R199GFW) and antigenomic (i.e. R199GREV) strand of HDV RNA were only able to reverse transcribe from either the antigenomic or the genomic polarity of HDV RNA, respectively (Fig. 2 , HDVG and HDVAG RNA lanes). Since both polarities of HDV RNA were recovered when the cross-linked sample was immunoprecipitated with the 8WG16 mAb, we conclude that both polarities of HDV RNA associate with RNAP II within HeLa cells, which directly establishes the association of the human RNAP II with HDV RNA and strongly suggests its involvement in the synthesis of both strands of HDV RNA.
Although the RT-PCR reactions were not quantitative, the intensity of the bands corresponding to both polarities of HDV RNA co-immunoprecipitated using the 8WG16 mAb was similar. Because it has been established that genomic HDV RNA accumulates more than antigenomic HDV RNA in infected cells (Chen et al., 1986) , our results suggest a more efficient binding of RNAP II to the antigenomic polarity of HDV RNA. To confirm the preferential interaction of RNAP II with this polarity, semi-quantitative RT-PCR was performed on RNA samples taken either before or after co-immunoprecipitation with the 8WG16 mAb. Because no human RNA is expected to co-immunoprecipitate with RNAP II, it was not possible to normalize the different samples using an internal RNA control. To circumvent this difficulty, amplification curves were performed and used to determine the number of PCR cycles at which all the samples were within their linear phase of amplification. Then, the intensities of the cDNA bands corresponding to both polarities of HDV RNA were compared within each sample. Prior to co-immunoprecipitation, we found a genomic:antigenomic HDV RNA ratio of 1.99:1. Although less than reported using infected liver cells, this value is in conformity with a greater intracellular abundance of genomic HDV RNA when compared to antigenomic HDV RNA (Chen et al., 1986) . By performing a similar calculation for the sample co-immunoprecipitated with the 8WG16 mAb, we found that the genomic:antigenomic HDV RNA ratio shifted to 1:1.56. As a result, under our conditions, antigenomic HDV RNA was enriched 3.1-fold after co-immunoprecipitation with the 8WG16 mAb. This enrichment indicates a preferential interaction of RNAP II with antigenomic HDV RNA.
RNAP II interacts with the terminal stem-loop domains of both polarities of HDV RNA in HeLa NE
The previous experiments provide evidence of the association of RNAP II with both the genomic and antigenomic HDV RNAs within HeLa cells. To determine the regions of the HDV RNA genome responsible for this interaction, we investigated the association of RNAP II with various HDV-derived RNAs in vitro using HeLa NE. As an initial step, both polarities of the HDV RNA genome were arbitrarily divided in three domains: 213 nt RNAs corresponding to what we refer to as the left terminal stem-loop (L213; nt 687 to 900), RNAs corresponding to the double-stranded central region (CENTR; nt 681 to 54 and nt 900 to 1540), and 199 nt RNAs corresponding to the right terminal stem-loop (R199; nt 1540 to 60). To guarantee that both RNA molecules forming the CENTR RNAs annealed, both strands were mixed, heated, slowly cooled, and tested for double-strand formation. Electrophoresis on a native acrylamide gel confirmed that most of the RNA molecules forming the CENTR RNAs annealed under our conditions (data not shown). The various radiolabeled HDV-derived RNAs were allowed to form RNAprotein complexes with HeLa NE proteins. The 8WG16 mAb was then added, the samples were immunoprecipitated using protein-G agarose beads, and the co-immunoprecipitated complexes were then subjected to denaturing gel electophoresis.
A typical gel using a radiolabeled RNA corresponding to the right terminal stem-loop domain of the genomic polarity of HDV RNA (i.e. R199G) is shown in Fig. 3A . Under our conditions, a band corresponding to the radiolabeled RNA was detected when the sample was immunoprecipitated using the 8WG16 mAb in the presence of HeLa NE. This band was not detected in the absence of NE or when the 8WG16 mAb was replaced with the anti-mouse IgG mAb, indicating that the signal observed was not the result of non-specific binding of R199G to the protein-G agarose beads or to the 8WG16 mAb. To ensure the specificity of the interaction, various RNA competitors were tested. When an excess of unlabeled homologous competitor was used, the intensity of the band corresponding to the radiolabeled R199G was considerably diminished. When poly-A RNA was used as an unrelated RNA competitor, no significant decrease in the co-immunoprecipitation of the radiolabeled R199G was observed. When acting on a DNA promoter, RNAP II binds to double-stranded nucleic acid. To verify that the observed association between RNAP II and R199G was not caused by non-specific affinity for doublestranded RNA, a small RNA hairpin (Fig. 3C, P11 .60) derived from the peach latent mosaic viroid (PLMVd) that acts as an RNA promoter for the Escherichia coli RNAP (Pelchat et al., 2002) was used as a competitor. The interaction between RNAP II and R199G was not significantly decreased by addition of an excess amount of P11.60. Taken together, these observations demonstrate that RNAP II interacts specifically with R199G within HeLa NE.
The interaction of RNAP II with the various regions of both genomic and antigenomic HDV RNA iS summarized in Fig.  3B . Because several RNA molecules were tested, only the lanes corresponding to the amount of RNA used and co-immunoprecipitation reactions in the presence of the non-specific RNA competitor P11.60 with either the absence (−NE) or the presence (+NE) of HeLa NE are presented. Under our conditions, both polarities of the complete HDV RNA genome co-immunoprecipitated specifically using the 8WG16 mAb (Fig. 3B, HDVG and HDVAG) . When the band intensities of the co-immunoprecipitated RNAs were normalized using the amount of radiolabeled RNA used, the antigenomic HDV RNA (HDVAG) was found to be co-immunoprecipitated 1.9-fold more efficiently than the genomic HDV RNA (HDVG). These results are in agreement with our previous observations using cross-linked lysates and indicate that RNAP II interacts more efficiently with the antigenomic polarity of HDV RNA.
Next, the various HDV-derived RNAs corresponding to the three arbitrary domains of both polarities were tested to determine the regions on the HDV RNA genome responsible for RNAP II interaction. Radioactive bands corresponding to the stem-loop domains of both polarities of HDV RNA (i.e. R199G, R199AG, L213G, and L213AG) were detected, whereas bands corresponding to the central regions of both polarities of HDV RNA (i.e. CENTRG and CENTRAG) were not. These results indicate that RNAP II interacting sites are located predominantly between nt 1540 to 60 and nt 687 to 900 on both polarities of the HDV RNA genome.
To further refine the regions interacting with RNAP II, smaller HDV-derived transcripts were synthesized and were used in the co-immunoprecipitation reactions. Specifically, R38 and L48, which correspond to 38 and 48 nt RNAs located at the tip of the right and the left hairpin domains, respectively, were tested for RNAP II interaction. Using the same co-immunoprecipitation conditions as above, we found that both polarities of R38 and L48 were able to co-immunoprecipitate using the 8WG16 mAb (Fig. 3C) , indicating that the terminal stem-loop domains of both polarities of HDV RNA can be reduced to smaller hairpins without significantly affecting their interaction with RNAP II. As an additional negative control, P11.60 was tested directly in the co-immunoprecipitation reactions. The small PLMVd-derived RNA hairpin did not co-immunoprecipitate with RNAP II when using the 8WG16 mAb (Fig. 3C) , which further supports the specificity of the co-immunoprecipitation experiments. Because RNAP II complexes are composed of many subunits and other related factors (Cramer, 2002) , we cannot conclude that the binding of the RNAP II core enzyme to the various RNA molecules is direct. Also, we cannot exclude the possibility that other RNAPs might be able to recognize these RNA fragments. However, these results provide direct evidence that a complex containing the CTD of the largest subunit of RNAP II interacts specifically with the terminal stem-loop domains of both polarities of HDV RNA in HeLa NE.
Sequence and secondary structure analysis of the terminal stem-loop domains of both polarities of HDV RNA To interact with HDV RNA, RNAP II must recognize specific features (i.e. sequences and/or secondary structures) on both polarities of the terminal stem-loop domains. We have taken advantage of the large number of known nucleotide sequences of in vivo selected variants to identify the features of terminal stem-loop domains of HDV RNA by studying positions of covariation and nucleotide conservation.
We collected the sequences corresponding to R38 and L48 from a total of 81 variants representing the various HDV genotypes indexed in the Subviral RNA Database (Rocheleau and Pelchat, 2006) . First, we aligned all the RNA sequences using the Clustal software (Thompson et al., 1994) , which generated a tree showing the sequence differences between HDV genotypes. Due to the imperfect alignment of the analyzed regions among the different HDV sequences, we applied alignments to smaller data sets according to HDV genotypes because of their lower degree of heterogeneity. For each of these genotypes, the consensus features of the RNA secondary structures generated by analysis of base-pair covariation were determined. Finally, we combined alignments by insertion of gaps so that homologous motifs (i.e. secondary structures) were Kuo et al. (1988a) . One tenth of the RNAs used for each coimmunoprecipitation are used as markers. The co-immunoprecipitations presented in panels B -D were performed in the presence of a 20-fold excess P11.60, as a non-specific RNA competitor.
superimposed. Using the consensus sequence derived from the alignment, the most thermodynamically stable secondary structure was predicted and re-adjusted based on the base-pair covariation data. Sequence conservation and the resulting consensus RNA secondary structures for both polarities of R38 and L48 are summarized in Fig. 4 together with the fully conserved nucleotides (red nucleotides) and the location of the base-pairs predicted by the covariation analysis (blue circles).
Despite heterogeneity among the different sequences and genotypes, base-pair covariation analysis indicates a strong selective pressure to maintain the rod-like conformation of these regions in which most of the base-pairs can be predicted. A few nucleotides within this region are conserved across all the HDV sequences examined (Fig. 4, red nucleotides) . Considering the degree of nucleotide divergence in the adjacent nucleotides, the observed conservation suggests a functional role for the conserved nucleotides. Strikingly, a short double-stranded stem (CUC/GAG) was found to be exceptionally conserved (Fig. 4B, yellow box) . In fact, most of the nucleotides comprising this short CUC/GAG stem are completely conserved in all the analyzed variants and the other positions exhibit only minor variations. Notably, we observed a strong polarization in the purine/pyrimidine content near the tip of the rod up to the end of the CUC/GAG stem in all the sequences analyzed. A region of 12 nt upstream of the terminal loop of R38G and R38AG exhibits an average of 91.0 ± 1.0% pyrimidine content which is matched by a region on the opposite strand containing almost exclusively purines (Fig.  4B ). In the case of L48G and L48AG, the sequence upstream of the loop contains 86.7 ± 5.9% pyrimidines which is matched by a region on the opposite strand having 82.0 ± 5.8% purines (Fig. 4B) .
The secondary structure and the polarization in the purine/ pyrimidine content near the tip of the rod are required for RNAP II interaction Sequence analysis of natural HDV variants suggests that the maintenance of the rod-like conformation and the polarization in the purine/pyrimidine content near the tip of the rod of both polarities of HDV RNA might be required for RNAP II interaction. We therefore introduced substitutions to R38G and L48AG aimed at destabilizing either of these conserved features. First, the involvement of the purine-rich segments located downstream of the terminal loops was investigated. R38GPY and L48AGPY are derivative RNAs in which the purine-rich segments were mutated to the pyrimidine-rich sequences located on their respective upper strands. Upon co-immunoprecipitation using the 8WG16 mAb, no significant association of RNAP II with either R38GPY or L48AGPY was detected (Fig. 3D) . Similar results were obtained when R38GPU and L48AGPU, two derivative RNAs in which the pyrimidine-rich segments located upstream of the terminal loops were mutated to purine-rich sequences, were used. Specifically, no co-immunoprecipitation of either R3G8PU or L48AGPU with RNAP II was detected (Fig. 3D) .
Because the mutations found in these four mutants also result in the disruption of their predicted rod-like structures, the absence of RNAP II interaction with these RNAs could be the result of the loss of their rod-like conformation. R38GSW and L48AGSW, which contain compensatory mutations that restore the predicted secondary structure of these hairpins, were therefore synthesized and tested for association with RNAP II. No complex formation was detected when using either of these "flip" mutants (Fig. 3D) . Taken together, these results are in accordance with the sequence analysis of natural HDV variants and indicate that the association of RNAP II with these regions is dependent on the conformation and on the polarization in the purine/pyrimidine content near the tip of the rod.
Discussion
The mechanism of RNA synthesis is highly conserved and can be roughly divided into three distinct phases: initiation, elongation, and termination. For initiation to occur, RNAPs search for and bind to promoter sequences to form a "closed complex"; thus, association of RNAP II would indicate sites of transcription (Smale and Kadonaga, 2003) . Here, we have used an antibody raised against the CTD of RNAP II to clarify RNAP II interaction with HDV RNA by studying the first step of the transcription process (i.e. promoter recognition). This approach was used to directly demonstrate specific RNAP II interaction with HDV RNA, both in vivo within HeLa cells and in vitro using HeLa NE. Using various HDV-derived RNAs with HeLa NE proteins, we have shown that specific RNAP II interaction occurs in vitro predominantly via small domains located at the extremities of both polarities of the rod-like secondary structure of the HDV RNA genome, and that RNAP II might bind more efficiently to the antigenomic polarity of HDV RNA.
It is possible that the observed interaction of RNAP II with these regions might not lead to transcription initiation. When binding to a DNA promoter, the RNAP II found within an initiation site is hypophosphorylated at its C-terminal domain (CTD) and is distinct from the elongating or terminating forms of the enzyme that are hyperphosphorylated (Hahn, 2004; Sims et al., 2004) . In this study, we have used the 8WG16 mAb, which specifically recognizes the unphosphorylated RNAP II CTD (Patturajan et al., 1998) ; the extremities of both polarities of HDV RNA are thus likely to be sites of pre-initiation complex formation (i.e. active promoters; Thompson et al., 1989; Smale and Kadonaga, 2003) . Moreover, most of these interaction sites are in agreement with previous reports.
The 5′-end of HDAg mRNA corresponds to an initiation site located within R38G (Gudima et al., 2000) . It is thus likely that the right terminal stem-loop domain contains an RNA promoter recognized by RNAP II. RNA fragments similar to both R199G and L213AG were reported to be able to initiate polymerization in vitro using HDV-derived RNAs and HeLa NE (Beard et al., 1996; Filipovska and Konarska, 2000) . Interestingly, transcription from the RNA template similar to L213AG did not proceed by de novo initiation, but rather by cleavage of the RNA template, followed by extension of the new 3′-end, generating a chimeric template/transcript product (Filipovska and Konarska, 2000) . An RNA fragment similar to L213G was also able to generate a specific product in this system, despite the authors' claim that the signal detected did not correspond to their typical chimeric template/transcript product (Filipovska and Konarska, 2000) . Here, we have shown that the right terminal stem-loop region of antigenomic HDV RNA (i.e. R199AG) can also interact with RNAP II and we have demonstrated that these four RNA regions can be reduced significantly in length without affecting RNAP II interaction. In summary, our results suggest the involvement of RNAP II in the synthesis of both genomic and antigenomic HDV RNAs. In addition, because RNAP II interacts with the extremities of both polarities of the HDV RNA genome, our data suggest the existence of two transcription/replication start sites for both genomic and antigenomic HDV RNAs. Moreover, it is possible that other RNAP(s) are involved in HDV transcription/replication, given that only the 8WG16 mAb was tested.
The RNA fragments interacting with RNAP II were further investigated by taking advantage of a large number of natural HDV variants. Analysis of base-pair covariation indicated that although changes in the primary sequence of these segments might be tolerated, their respective secondary structures are most likely critical for HDV replication/accumulation. The conserved features of the two extremities of the rod-shaped HDV RNA are very similar. Our analysis revealed a highly ordered RNA secondary structure that is comprised of regions of double-stranded RNA with a conserved CUC/GAG triple base-pair motif and one strand of pyrimidines upstream of a 3-8 nt terminal loop followed by a complementary strand of purines. Because these features are found near all the terminal loops of HDV RNA which were shown to interact with RNAP II, it is tempting to suggest the involvement of these features in RNAP II binding. Accordingly, mutagenesis of R38G and L48AG, affecting the conformation and the polarization in the purine/pyrimidine content near the tip of the rod, indicated that the interaction of RNAP II with these regions is dependent on these features.
Previous studies have reported extensive mutagenesis on the extremities of the rod-like structure of HDV RNA and have observed their effects on HDV RNA accumulation in vivo (Beard et al., 1996; Gudima et al., 1999 Gudima et al., , 2006 Wang et al., 1997; Wu et al., 1997) . Fig. 5 presents a summary of these published results. For the right terminal extremities, variation of the terminal loop sequence and size had no effect on HDV RNA accumulation (Gudima et al., 1999; Wu et al., 1997) . In contrast, disruption of the overall rod-like conformation of this region or even small changes in the terminal stem had major effects on accumulation of HDV RNA (Beard et al., 1996; Gudima et al., 1999; Wu et al., 1997) . In addition, HDV RNA accumulation was found to be sensitive to the size of the 3 nt external bulge, which includes the putative mRNA initiation site (Gudima et al., 1999) . Our analysis indicates that this bulge can be on either side of the stem-loop structures and RNAP II interaction still occurs (compare R38R/R38AG). However, correct positioning of this non-paired region might be critical for the initiation stage of HDAg mRNA synthesis. Noteworthy, a "flip" mutant in the terminal stem was found to greatly affect HDV RNA accumulation in complete agreement with our results. The association of RNAP II with this region and initiation of transcription are thus dependent on the conformation and on the polarization in the purine/pyrimidine content near the tip of the rod.
Conversely, the left-terminal region was found to be highly tolerant to nucleotide changes within the loop and to insertions as well as deletions in the adjacent stem region . Only the removal of large segments or the insertion of various non-HDV sequences in the conserved CUC/GAG motifs resulted in loss of accumulation of HDV RNA (Gudima et al., 2006; Wang et al., 1997) . Interestingly, most genomes containing large inserts lost their inserted sequences suggesting the involvement of this region in HDV RNA replication (Gudima et al., 2006) . The divergence of these reports with our results might be explained by the likely involvement of another RNAP, such as RNAP I. Moreover, because RNAP II was found to be associated with the stemloop region of both polarities of HDV RNA, suggesting at least two replication start sites for each polarity of HDV RNA, complementation of replication impaired mutants of the left-terminal stem-loop structure might occur. Since the right extremity contains sequences required for HDAg mRNA transcription, such complementation might not occur, causing the right terminal stem-loop region to be more sensitive to mutation.
We cannot exclude the possibility that the conserved features of the HDV extremities might also be linked to activities unrelated to RNAP II binding, such as RNA stabilization, RNA transportation, or RNA encapsidation. For example, these polypyrimidine/polypurine tracts could serve as binding sites for other RNA-binding proteins. Typical representatives of these types of proteins are the polypyrimidine tract-binding (PTB) proteins and the heterogeneous nuclear ribonucleoproteins (hnRNPs), which, in uninfected cells, are involved in a variety of processes, such as pre-mRNA splicing in the nucleus (Garcia-Blanco et al., 1989; Swanson and Dreyfuss, 1988) . However, we recently reported the finding that the polypyrimidine tract-binding protein-associated splicing factor (PSF) is also able to bind specifically to both polarities of HDV through the terminal stem-loop domains of the rod-like structure (Greco-Stewart et al., in press ). Because PSF is known to bind to the CTD of RNAP II (Emili et al., 2002) and PSF binding sites correlate with the locations on the HDV RNA genome found to be associated with RNAP II, it is tempting to suggest that by interacting with both an HDV RNA promoter and RNAP II, PSF or another polypyrimidine/polypurine tractbinding protein might provide docking sites or assist RNAP(s) in the formation of pre-initiation complexes. The co-immunoprecipitation assay we used in this study will be a perfect tool in determining the content of the RNAP II complex interacting with HDV RNA and the contribution of additional trans-acting host factors in RNA promoter recognition by RNAP II. For instance, although HDAg-S was demonstrated to be essential for HDV accumulation (Kuo et al., 1989) , our results indicate Beard et al., 1996, (b) Wu et al., 1997, (c) Wang et al., 1997, and Gudima et al., 1999 . Reported mutagenesis on either the right-or the left-terminal extremities of the rod-like secondary structure of the HDV RNA are presented in panels A or B, respectively. that this protein is not required for the interaction of RNAP II with HDV RNAs in HeLa NE since it was absent from all coimmunoprecipitation assays. This observation correlates with previous results suggesting that HDAg-S could regulate the elongation phase of transcription by binding to RNAP II directly and by displacing the negative elongation factor (Yamaguchi et al., 2001) .
Interestingly, the features and the locations of RNAP II interaction sites on HDV RNA share structural similarities with DNA-dependent RNAP binding and/or initiation sites reported for other related subviral RNAs. E. coli RNAP can bind to and transcribe from a stem-loop domain derived from the PLMVd genome (Pelchat et al., 2002; Pelchat and Perreault, 2004) . Any structural alterations that disrupt the overall rod-like conformation of the RNA template were shown to interfere with de novo transcription by E. coli RNAP (Pelchat et al., 2002; Pelchat and Perreault, 2004) . Replication of the avocado sunblotch viroid genome is proposed to initiate within large terminal loops (Navarro and Flores, 2000) . Wheat germ RNAP II was shown to bind to the large terminal loops of potato spindle tuber viroid genome (Goodman et al., 1984) , and it was recently reported that potato NE was able to initiate transcription of this viroid within a terminal stem-loop region of the RNA genome (Kolonko et al., 2006) .
It is now known that the observed structural similarities between bacterial RNAP and eukaryotic RNAP II involve not only similarity in overall structural organization, but also detailed similarity in folding topologies of subunits (Cramer, 2002) . In view of the similarities between the RNAPs and the similarities between the various subviral RNA domains reported to bind DNA-dependent RNAP, it is tempting to suggest a common mechanism of RNAP recognition acting on subviral RNA species. It seems clear that a defined hairpin domain is a common feature of RNA promoters for these DNA-dependent RNAPs. Such terminal stem-loop secondary structures with RNA features specific for each RNAP could thus represent "universal" RNA binding sites and/or promoter elements for these DNA-dependent RNAPs.
Materials and methods
Synthesis of HDV-derived RNAs
Polymerase chain reaction (PCR) with Vent polymerase (New England Biolabs; NEB) was used to amplify DNA fragments for the synthesis of both genomic and antigenomic cDNA fragments from a derivative of pBluescriptKS + (Stratagene) containing dimeric HDV genomic cDNA (Kuo et al., 1988a) flanked by T7 and T3 promoter recognition sites. P11.60 was synthetized as previously described (Pelchat and Perreault, 2004) . All R38 and L48 derivatives were transcribed from double-stranded DNA oligonucleotides possessing a T7 RNA promoter. DNA products were used for in vitro run off transcription using T7 RNA polymerase (NEB). HDV dimeric RNA genomes were similarly synthesized using linearized plasmid containing a dimer of HDV cDNA as a template for transcription. After incubation of the transcription reactions at 37°C for 2 h, the reactions were treated with DNase I (Promega) for an additional 30 min. The RNA products were electrophoresed on denaturing 5% or 10% polyacrylamide gels in 1× TBE buffer (100 mM Tris-borate, pH 8.3, 1 mM EDTA) and 7 M urea. Following electrophoresis, UV shadowing was used to detect the RNA bands, which were subsequently excised, eluted overnight at 4°C in elution buffer (500 mM ammonium acetate, 0.1% SDS, 20 mM EDTA), precipitated with ethanol, and resuspended in H 2 O. Debris and residual urea were removed by passage through Sephadex G-50 columns (Amersham Pharmacia Biotech) and the RNAs were precipitated with ethanol, resuspended in H 2 O, quantified by spectrophotometry at 260 nm, and stored at − 20°C. CENTR molecules were generated using two RNA strands folded together by heat denaturation at 94°C and slow renaturation at room temperature in 40 mM Tris-HCl, pH 8.0/10 mM MgCl 2 .
Immunoprecipitation of HDV-derived RNAs
The Protein-G Immunoprecipitation Kit (Sigma-Aldrich) was employed to co-immunoprecipitate HDV RNAs in accordance with the manufacturer's protocol. Briefly, 5 pmol of RNA was 5′-end radiolabeled with [γ-32 P]ATP as previously described (Pelchat et al., 2002) and incubated with 26 μg of HeLaScribe Nuclear Extract (Promega) in RIP buffer (50 mM Tris-Cl, pH 7.5, 1% Nonidet P-40 (NP-40), 0.5% sodium deoxycholate, 0.05% SDS, 1 mM EDTA, 150 mM NaCl; Niranjanakumari et al., 2002) at 37°C for 30 min. A 20-fold excess of poly-A RNA or P11.60 was added to some reactions as non-specific competitors. A 20-fold excess of cold homologous RNA was used as a specific competitor. Approximately 5 μg of either mouse monoclonal antibody (8WG16; Upstate) directed against the Rpb1 C-terminal domain (CTD) of RNAP II or goat anti-mouse IgG (Sigma-Aldrich) was then added to the reaction mixtures and they were incubated for 2 h at 4°C on a rotator. Pre-washed protein-G beads were then added to the mixtures and incubated overnight as above. Following incubation, reactions were centrifuged, washed 5 times in RIP buffer, once with 0.1× RIP buffer, and eluted according to manufacturer's protocols in acrylamide loading buffer (Sambrook et al., 1989) . Samples were electrophoresed on denaturing 10% polyacrylamide gels and the bands were detected by autoradiography or phosphorimager scanning (Molecular Dynamics).
Ribonucleoprotein immunoprecipitation (RIP) assay
The RIP assay was performed as previously described (Niranjanakumari et al., 2002) with some modification. HeLa cells were transfected with 6 μg of pcDNA3-AgS and 10 μg of dimeric HDV RNA genome of positive polarity using Lipofectamine TM 2000 Reagent (Invitrogen) in accordance with manufacturer's protocol. pcDNA3-AgS is a derivative of pcDNA3 (Stratagene) encoding the small delta antigen under the control of a CMV promoter (Lazinski and Taylor, 1993) . Formaldehyde (1%) was used to cross-link nucleic acids to cellular proteins for 5 min at 37°C. About 10 6 cells were harvested by centrifugation, washed twice with ice-cold PBS, the supernatant decanted, and pellets stored at − 80°C. Cells were resuspended in 2 ml RIP buffer, homogenized by sonication, and centrifuged at 16,000 × g for 30 min at 4°C. Immunoprecipitation was performed using the Protein-G Immunoprecipitation Kit as above using 500 μl of cell lysate. Samples were washed 5 times with high-stringency RIP wash buffer containing 1 M urea (Niranjanakumari et al., 2002) , heated to 70°C for 45 min in a solution of 50 mM Tris-HCl, pH 7.0, 5 mM EDTA, 10 mM dithiotriol (DTT), and 1% SDS to reverse the cross-links, and eluted by centrifugation. The nucleic acids were extracted by phenol/chloroform, ethanol precipitated, resuspended in H 2 O, and treated with DNAse I (Promega) for 45 min at 37°C. After a second RNA extraction with phenol/chloroform and precipitation with ethanol, the RNA was resuspended in H 2 O. The RNA was heated for 5 min at 65°C with 1 pmol of one of the primers used to generate the R199G cDNA (R199GFW: 5′-G G A AT T C TA ATA C G A C T C A C TATA G G G 1541 A C T-GCTCGAGGATCTCTTCTCTCCC 1565 -3′ or R199GREV: 5′-GGAATTC 60 ACATCCCCTCTCGGGTGC 43 -3′; underlined nucleotides indicate the T7 promoter) in 5 μl of annealing buffer (50 mM Tris-HCl, pH 8.3, 10 mM MgCl 2 , 80 mM KCl solution), and then the mixture quickly snap frozen by immersion in −80°C ethanol/dry ice for 2 min. Synthesis was performed by adding 4 units avian myeloblastosis virus reverse transcriptase (Amersham Pharmacia Biotech) in 5 μl of ice cold annealing buffer containing 8 mM DTTand 4 mM dNTP to the primer annealed templates, and then incubating at 42°C for 30 min. The cDNA was extracted by phenol/chloroform, ethanol precipitated, and resuspended in H 2 O. PCR amplification using the same primers was composed of 35 cycles of denaturation at 94°C for 1 min, annealing at 50°C for 1 min, and extension at 76°C for 1°min. The primer B-ActinREV (5′-GGGGTACTTCAGGGTGAGGATGCCTCTCTT-3′) for the RT reaction and both B-ActinREV and B-ActinFW (5′-ATG-GATGATGATATCGCCGCGCTCGTCGTC-3′) were used to perform RT-PCR to generate a small 200 nt cDNA fragment corresponding to the 5′-end of the β-actin mRNA. Bands were resolved by 2% agarose gel electrophoresis and visualized under UV light in the presence of ethidium bromide. Semi-quantitative RT-PCR was performed as above by ending the PCR amplification during the linear phase of amplification. Amplification curves were carried out by real-time RT-PCR of HDV RNA performed with an ABI Prism 7300 DNA analyzer (Applied Biosystems) in the presence of SYBR Green (Invitrogen).
Computer analysis of putative HDV promoter sequences.
All the HDV sequences were taken from the Subviral RNA Database (http://subviral.med.uottawa.ca/; Rocheleau and Pelchat, 2006) . Multiple alignments of HDV sequences were obtained using ClustalW (Thompson et al., 1994) . The alignments were corrected manually to maximize sequence identities and secondary structural features. Covariation analyses were performed using BioEdit v7.0.5 (Brown, 1991) . Thermodynamic parameters of RNA promoters were established for each secondary structure using the RNAeval Software from the Vienna RNA Structure Software Suite (Hofacker, 2003) . Logos were generated using WebLogo (Crooks et al., 2004) .
